Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.48% | 171.28 | 1.3% | $490.30m | |
| BIIB | Biogen Inc. | -0.90% | 227.06 | 1.3% | $435.96m | |
| CELG | Celgene Corporation | -0.41% | 95.24 | 1.3% | $435.38m | |
| GILD | Gilead Sciences, Inc. | -0.42% | 66.89 | 0.9% | $421.14m | |
| ILMN | Illumina, Inc. | 1.13% | 312.45 | 3.5% | $304.49m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.86% | 312.56 | 2.6% | $284.79m | |
| A | Agilent Technologies, Inc. | 0.99% | 68.37 | 1.6% | $218.10m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.72% | 171.77 | 1.9% | $178.12m | |
| EXAS | Exact Sciences Corporation | 3.06% | 96.88 | 25.3% | $165.46m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.45% | 127.15 | 2.0% | $148.25m | |
| BMRN | BioMarin Pharmaceutical Inc. | 2.42% | 89.07 | 4.3% | $119.32m | |
| INCY | Incyte Corporation | 1.55% | 81.75 | 2.5% | $110.60m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.19% | 120.84 | 14.7% | $106.75m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.50% | 68.93 | 9.2% | $99.72m | |
| IONS | Ionis Pharmaceuticals, Inc. | -3.60% | 64.72 | 8.2% | $96.34m |
Company Profile
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.